🔍
Detection of Prostate Cancer Proteins in Serum for Cancer Diagnosis with a Blood Test
Case ID:
C10088
Report of Invention:
6/2/2007
Web Published:
10/27/2021
There is a crucial need of discovering novel biomarkers in addition to prostate specific antigen (PSA) to improve the specificity of clinical diagnosis for prostate cancer. This invention addresses this problem by discovering proteins from prostate cancer tissues that can be detected in patients’ blood. Hence, a blood test can be developed for detecting prostate cancer at an early, more curable stage, and to molecularly define the cancer stage for an accurate prognosis. Additional advantages of this discovery include:
• Diagnostic markers for prostate cancer risk assessment
• Potential development of novel therapeutic strategies
Publications:
US8603734
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Biomarkers for Prostate Cancer
PCT: Patent Cooperation Treaty
United States
12/663,191
8,603,734
6/14/2010
12/10/2013
6/4/2028
Granted
Direct Link:
https://jhu.technologypublisher.com/technology/45186
Inventors:
Category(s):
Clinical and Disease Specializations, Clinical and Disease Specializations > Men's Health, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools > Assays, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools, Clinical and Disease Specializations > Oncology > Prostate Cancer,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum